key

Dexamethasone acetate (NSC 39471) is the acetate salt form of Dexamethasone, a synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones.

Anti-Human/Mouse/Monkey PD-1 Antibody (2E5) is a monoclonal inhibitory antibody targeting PD-1. PD-1 is a cell membrane receptor mainly expressed on the surface of T cells and pre-B cells. Binding of PD-1 to its ligands PD-L1 and PD-L2 reduces the body’s immune response by inhibiting T cell activation. Therefore, PD-1 serves as a key immune checkpoint and an important target for the development of targeted antibody drugs for various malignant tumors.

Monkeypox virus resolvase-IN-1 (compound 5-1) is a potent inhibitor of the monkeypox virus resolvase (Mpr), with an IC50 of 36 nM. It exhibits antiviral activity against the vaccinia virus (VACV, a model orthopoxvirus), with an EC50 of 3.2 nM. Monkeypox virus resolvase-IN-1 is applicable in antiviral research.

The LOC771 Monkey Pre-designed siRNA Set A consists of three pairs of siRNA targeting distinct regions of the LOC771 (Monkey) gene. It also includes a negative control, a FAM-labeled negative control, and a positive control.

The SP1 Monkey Pre-designed siRNA Set A consists of three pairs of siRNAs targeting various regions of the SP1 (Monkey) gene, along with a negative control, a FAM-labeled negative control, and a positive control.

Parkeyl acetate is a bioactive chemical.

Cyclic MKEY TFA, a synthetic cyclic peptide, inhibits CXCL4-CCL5 heterodimer formation, thus guarding against atherosclerosis and aortic aneurysm by mitigating inflammation. Additionally, it affords protection against stroke-induced brain injury in mice [1] [2].

Anti-Mouse/Rat/Monkey/Human ICOS/CD278 Antibody (C398.4A) is a monoclonal inhibitory antibody targeting mouse, rat, monkey, and human ICOS/CD278. It can be used in research on tumors and infectious diseases, including glioma and hepatitis B virus infection.

Anti-Monkey/Human MDR-1/CD243 Antibody (UIC2) is an IgG2a, κ monoclonal antibody derived from mice, designed to inhibit MDR-1/CD243 proteins in monkeys or humans.

Anti-Monkey/Human CD28 Antibody (CD28.2) is a mouse-derived inhibitory antibody targeting monkey/human CD28.Anti-Monkey/Human CD28 Antibody (CD28.2) blocks CD28 signaling and is suitable for immunological research.

Anti-Monkey/Human CD20 Antibody (2H7) is a mouse-derived antibody that specifically targets the CD20 antigen in monkeys and humans and exerts an inhibitory effect. It achieves selective depletion of B cells through its targeting action and is commonly used in research on inflammatory and metabolic diseases such as diabetes and experimental autoimmune encephalomyelitis (EAE).

Anti-Human/Monkey CD16a Antibody (3G8) is a monoclonal inhibitory antibody targeting human and monkey CD16a, which can be used in immunological research.

Anti-Human/Mouse/Monkey CXCR3 Antibody (9C5) is a monoclonal inhibitory antibody targeting human, mouse, and monkey CXCR3, applicable to immunological research.

Anti-Human/Monkey/Canine IL-17A Antibody (Mab7) is a monoclonal inhibitory antibody targeting human, monkey, and canine IL-17A, applicable to inflammation-related research.

Anti-Human/Mouse/Rat/Monkey/Canine/Rabbit IL-1b Antibody (AB7) is an inhibitory antibody that targets IL-1β in human, mouse, rat, monkey, canine, and rabbit, suitable for inflammation-related research.

Anti-Human/Monkey NKG2D Antibody (16F16) is a monoclonal inhibitory antibody targeting human and monkey NKG2D, applicable to tumor immunotherapy research.

Anti-Human/Monkey NKG2D Antibody (ON72) is an inhibitory antibody targeting human and monkey NKG2D, suitable for research related to cancer immunotherapy.

Anti-Human/Mouse/Monkey CLDN18.2 Antibody (25C7A5-HZ1) is an inhibitory antibody that targets Claudin-18.2 in humans, mice, and monkeys, and is suitable for use in cancer-related research.

Anti-Human/Mouse/Monkey TL1A Antibody (1D1) is a monoclonal inhibitory antibody that blocks the TL1A/DR3 pathway, inhibits abnormal PI3K/AKT activation, corrects Th1/Th17 imbalance, and reduces pulmonary granuloma formation.

Anti-Human/Monkey CD28 Antibody (2D8.S) is a monoclonal antibody targeting human and monkey CD28. It can be used for T-cell costimulation research.

Anti-Human/Monkey CXCR4 Antibody (12G5) is an antibody targeting Human/Monkey CXCR4 and can be used for immunology research.

Anti-Monkey/Human CD40L/CD154 Antibody (5C8) is a mouse inhibitory antibody targeting monkey/human CD40L/CD154, blocking the interaction between CD154 and CD40. It can be used in inflammation and immunology-related research, including colitis and transplantation studies.

Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) is an IgG antibody inhibitor targeting TGF-β in multiple species including mouse, human, rabbit, monkey, hamster, dog, and cow. For information on the isotype control, refer to Mouse IgG1 kappa, Isotype Control.

Anti-Monkey/Human MHC class II (HLA-DR) Antibody (L243) is an IgG2a, κ antibody inhibitor derived from mice that targets monkey or human MHC class II.